PYX Resources: Achieving volume and diversification milestones. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,775.00
Bid: 1,771.00
Ask: 1,771.50
Change: -8.50 (-0.48%)
Spread: 0.50 (0.028%)
Open: 1,773.50
High: 1,779.00
Low: 1,764.50
Prev. Close: 1,783.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London midday: Markets pull back from five-month high as banks fall

Wed, 23rd Oct 2013 11:15

Concerns over the Chinese economy and a weak performance by banking stocks halted a nine-day winning streak for UK markets on Wednesday, as investors chose to take profits following a strong run.The FTSE 100 snapped a nine-day winning streak this morning, pulling back from Tuesday's finish of 6,695.66, the index's highest closing high since May 28th when it closed at 6,762.01.Stocks have surged over the past week as investors celebrated the end to the US government shutdown and the short-term deal to raise the debt ceiling. Meanwhile, hopes over a continuation of Federal Reserve monetary stimulus were sparked yesterday after a disappointing September jobs report.Weighing on markets this morning was a sharp sell-off across Asian indices overnight on the back of concerns over the Chinese banking sector following a report that said that debt write-offs at the country's biggest lenders tripled in the first half. Investors were also focusing on the People's Bank of China's decision on Wednesday to refrain from adding liquidity to the market through new reverse repurchase operations, which led to a sharp increase in the country's benchmark money market rate. In other news, the minutes of the latest Bank of England meeting were released this morning and showed that the Monetary Policy Committee was unanimous in its decision to keep policy unchanged as recent economic data pointed to a "robust recovery in activity".Banks, ex-div stocks provide a dragBanks all over Europe were out of favour after the European Central Bank said it would start to review the balance sheets of 130 institutions across the continent. RBS, Barclays, Lloyds, HSBC and Standard Chartered were all registering losses in London.A number of stocks were also trading in the red after going ex-dividend, including Smiths Group, BAE System, Rolls-Royce, John Menzies, Senior, William Hill, Rank Group, Barratt Developments and JD Wetherspoon.Banknote printer and ID services firm De La Rue was a big mover with shares sinking after the company warned that it would miss its full-year profit target by £10m owing to "challenging trading conditions".Drugs group GlaxoSmithKline was also weighing on the market ahead of the release of its third-quarter results due out later on amid concerns over the impact of a corruption probe in China on sales.Chip designer ARM Holdings fell for the second straight day as investors gave a cool reaction to its third-quarter results. JPMorgan Cazenove said this morning that it sees "no reason to be building positions at this time and would take profits in the short term."Sports Direct edged higher after saying that sales in the nine weeks to September 29th were up 15.1% despite some tough comparatives with last year. Fellow retailer Home Retail also rose after a 53% jump in first-half profits owing to sales growth at its Argos and Homebase chains.Costa and Premier Inn owner Whitbread was lower after Deutsche Bank downgraded the stock to 'hold', saying that it's time to "consolidate and take stock" after a great year.Meanwhile, telecoms firm Vodafone was in demand as speculation continues to ramp up about a possible bid from US counterpart AT&T. Credit Suisse has raised its target for the UK-listed stock, saying it sees a 50% chance of a bid.FTSE 100 - RisersRSA Insurance Group (RSA) 127.00p +2.50%Persimmon (PSN) 1,244.00p +1.39%International Consolidated Airlines Group SA (CDI) (IAG) 363.80p +1.34%Travis Perkins (TPK) 1,804.00p +1.23%United Utilities Group (UU.) 713.50p +1.21%Resolution Ltd. (RSL) 351.40p +1.15%Legal & General Group (LGEN) 212.40p +1.14%Capita (CPI) 985.50p +1.13%Shire Plc (SHP) 2,521.00p +1.12%Weir Group (WEIR) 2,361.00p +1.11%FTSE 100 - FallersSmiths Group (SMIN) 1,394.00p -4.19%Anglo American (AAL) 1,510.00p -2.96%Antofagasta (ANTO) 878.00p -2.88%Royal Bank of Scotland Group (RBS) 353.20p -2.43%Rio Tinto (RIO) 3,187.00p -2.28%CRH (CRH) 1,513.00p -2.07%ARM Holdings (ARM) 983.50p -2.04%BHP Billiton (BLT) 1,914.50p -1.85%Barclays (BARC) 267.70p -1.80%GlaxoSmithKline (GSK) 1,575.00p -1.62%FTSE 250 - RisersLaird (LRD) 239.90p +6.29%Pace (PIC) 303.80p +4.76%Home Retail Group (HOME) 191.60p +3.96%African Barrick Gold (ABG) 172.60p +3.35%Kenmare Resources (KMR) 22.48p +3.26%IP Group (IPO) 145.90p +3.04%Alent (ALNT) 363.00p +2.25%Chemring Group (CHG) 219.80p +2.19%Telecom Plus (TEP) 1,514.00p +2.16%BH Global Ltd. USD Shares (BHGU) 11.63 +2.02%FTSE 250 - FallersDe La Rue (DLAR) 889.50p -9.33%International Personal Finance (IPF) 622.00p -6.96%Premier Oil (PMO) 323.10p -4.97%Telecity Group (TCY) 786.00p -4.96%Centamin (DI) (CEY) 49.65p -4.24%Evraz (EVR) 129.50p -3.50%Kazakhmys (KAZ) 253.40p -3.28%AZ Electronic Materials SA (DI) (AZEM) 288.80p -2.43%Soco International (SIA) 405.20p -1.89%Hansteen Holdings (HSTN) 106.00p -1.85%BC
More News
18 Sep 2023 07:18

US FDA approves GSK treatment for myelofibrosis

(Sharecast News) - GSK announced on Monday that the US Food and Drug Administration (FDA) has granted approval for 'Ojjaara', or momelotinib, as a treatment for adults suffering from intermediate or high-risk myelofibrosis with anaemia, including cases of primary myelofibrosis or secondary myelofibrosis.

Read more
15 Sep 2023 21:52

GSK's Ojjaara approved in US for myelofibrosis patients with anaemia

(Alliance News) - GSK PLC on Friday said Ojjaara, also known as momelotinib, has been approved in the US and the "first and only" treatment indicated for myelofibrosis patients with anaemia.

Read more
11 Sep 2023 08:24

Japan accepts GSK's regulatory filing for momelotinib for blood cancer

(Alliance News) - GSK PLC on Monday reported regulatory progress for momelotinib, as Japan's Ministry of Health, Labour & Welfare accepted a review for the blood cancer-focused drug.

Read more
11 Sep 2023 07:54

LONDON BRIEFING: Restaurant Group sells Frankie & Benny's and Chiquito

(Alliance News) - Stocks in London are called higher on Monday, ahead of a busy week of interest rate decisions and economic data.

Read more
6 Sep 2023 09:32

LONDON BROKER RATINGS: Shore says 'buy' B&M; Peel Hunt likes Halfords

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning:

Read more
4 Sep 2023 06:00

More UK babies to need hospital treatment over delay of GSK's RSV jab

(Alliance News) - The nation's top children's doctor has warned a delay on a new vaccine to combat respiratory syncytial virus, or RSV, will mean more babies and infants will need hospital treatment this winter.

Read more
1 Sep 2023 09:11

GSK antibody accepted for Japan review, Goldman Sachs reduces stake

(Alliance News) - GSK PLC on Friday said a new drug application for its monoclonal antibody mepolizumab has been accepted for review by the Japanese government.

Read more
1 Sep 2023 07:49

LONDON BRIEFING: Stocks seen higher; UK house prices continue to fall

(Alliance News) - Stocks in London are set to open higher on Friday as markets looked ahead to a data-heavy day.

Read more
1 Sep 2023 07:12

Japan considering GSK's Nucala drug for sinusitis treatment

(Sharecast News) - Japanese regulators are reviewing a new drug application for GSK's Nucala treatment to be used for the treatment of form of adult sinusitis, the biopharma giant announced on Friday.

Read more
23 Aug 2023 12:10

LONDON MARKET MIDDAY: Stocks rise but pound slumps on sub-par UK data

(Alliance News) - Stocks in Europe were on the up heading into Wednesday afternoon, with equity markets in a confident mood on the eve of the Jackson Hole central banking event, shaking off tepid economic data which hurt the pound and euro.

Read more
23 Aug 2023 08:17

GSK gets positive results from shingles trial of Shingrix in China

(Alliance News) - GSK PLC on Wednesday celebrated positive results from the first-ever efficacy trial of its preventative shingles treatment, Shingrix, in China.

Read more
23 Aug 2023 07:04

GSK reports positive results from shingles vaccine trials in China

(Sharecast News) - GSK reported significant positive findings from its first efficacy trial of the 'Shingrix' shingles vaccine in China on Wednesday.

Read more
22 Aug 2023 13:09

UK's Wood Group raises profit forecast on contract wins; shares rise

CFO David Kemp to retire

*

Read more
21 Aug 2023 22:37

US FDA approves Pfizer's maternal RSV vaccine to protect infants

Aug 21 (Reuters) - The U.S. Food and Drug Administration on Monday approved Pfizer's respiratory syncytial virus (RSV) vaccine for use in women during the middle of the third trimester of pregnancy to protect their babies.

Read more
17 Aug 2023 19:53

Charity says HIV drug deal with GSK's ViiV on ice over price secrecy

(Alliance News) - The Doctors Without Borders, or MSF, charity said Thursday a deal aimed to bring long-term preventative HIV treatment to vulnerable populations was on hold after the drugmaker imposed pricing confidentiality.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.